Table 1 General characteristics of the study population (n = 2151) according to sex and prevalence of CKD. The quantitative values are expressed by median and interquartile difference, qualitative values as number and percentage
From: Association between kidney function, nutritional status and anthropometric measures in older people
Variable | All n = 2151 | Men n = 932 | Women n = 1219 | CKD(−) group n = 818 | CKD(+) group n = 1333 |
|---|---|---|---|---|---|
Age (years) | 79.5 (5.9) | 79.5 (5.8) | 79.5 (5.9) | 78.6 (4.5) | 80.2 (6.2) c |
Men (n, %) | 932 (43.3) | – | – | 315 (38.5) | 617 (46.3) c |
Education (years) | 11 (7) | 12 (7) | 11 (7) a | 12 (8) | 11 (6) c |
Weight (kg) | 72.0 (17.5) | 78 (15.6) | 67 (16.3) c | 70 (18.4) | 74 (18.9) c |
Arm circumference (cm) | 28 (4.0) | 28 (3.5) | 28 (5.0) | 28 (4.0) | 28 (4.0) c |
Waist circumference (cm) | 98 (15) | 102 (14) | 95 (16) c | 96 (15) | 99 (16) c |
Hip circumference (cm) | 104 (11.0) | 104 (9.0) | 104 (14.0) a | 102 (10.1) | 105 (12.0) c |
Calf circumference (cm) | 36 (5.0) | 37 (5.0) | 35 (5.0) c | 36 (5.0) | 36 (6.0) c |
BMI (kg/m2) | 27.3 (5.6) | 27.2 (5.0) | 27.4 (6.3) | 26.7 (5.4) | 27.6 (5.7) c |
WHR | 0.93 (0.11) | 0.98 (0.09) | 0.89 (0.09) c | 0.92 (0.12) | 0.93 (0.11) c |
WHtR | 0.60 (0.10) | 0.60 (0.09) | 0.60 (0.10) | 0.59 (0.10) | 0.61 (0.09) c |
MNA SF | 13 (2) | 14 (2) | 13 (2) c | 13 (2) | 13 (2) |
MNA | 27.0 (3.0) | 27.0 (2.5) | 26.5 (3.0) c | 27.0 (2.5) | 26.5 (3.0) c |
Albumin (g/dL) | 4.22 (0.5) | 4.30 (0.5) | 4.20 (0.4) | 4.30 (0.4) | 4.20 (0.4) c |
Diabetes (n,%) | 532 (24.7) | 279 (29.9) | 253 (20.8) c | 154 (18.8) | 378 (28.4) c |
Cancer (n,%) | 368 (17.1) | 188 (20.2) | 180 (14.8) c | 116 (14.2) | 252 (18.9) b |
Hypertension (n,%) | 1635 (76.0) | 707 (75.9) | 928 (76.1) | 542 (66.3) | 1093 (82.0) c |
CAD (n,%) | 288 (13.4) | 171 (18.3) | 117 (9.6) c | 72 (8.8) | 216 (16.2) c |
CVD (n,%) | 268 (12.5) | 132 (14.2) | 136 (11.2) c | 87 (10.6) | 181 (13.6) a |
HF (n,%) | 335 (15.6) | 167 (17.9) | 168 (13.8) b | 68 (8.3) | 267 (20.0) c |
COPD (n,%) | 252 (11.7) | 156 (16.7) | 96 (7.9) c | 70 (8.6) | 182 (13.7) b |
Metabolic syndrome (n,%) | 1257 (58.4) | 555 (59.5) | 702 (57.6) | 403 (49.3) | 854 (64.1) c |
CIRS-G | 8 (6) | 8 (7) | 7 (7) c | 7 (6) | 9 (7) c |
Country | |||||
Austria (n, %) | 225 (10.5) | 117 (12.6) | 108 (8.9) b | 30 (3.7) | 195 (14.6) c |
Germany (n, %) | 270 (12.6) | 83 (8.9) | 187 (15.3) c | 106 (13.0) | 164 (12.3) |
Israel (n, %) | 299 (13.9) | 138 (14.8) | 161 (13.2) | 149 (18.2) | 150 (11.3) c |
Italy (n, %) | 436 (20.3) | 221 (23.7) | 215 (17.6) c | 155 (18.9) | 281 (21.1) |
The Netherlands (n, %) | 285 (13.2) | 160 (17.2) | 125 (10.3) c | 90 (11.0) | 195 (14.6) a |
Poland (n, %) | 352 (16.4) | 101 (10.8) | 251 (20.6) c | 160 (19.6) | 192 (14.4) b |
Spain (n, %) | 284 (13.2) | 112 (12.0) | 172 (14.1) | 128 (15.6) | 156 (11.7) b |